What is a common adverse effect associated with antiplatelet therapy after MI?

What is a common adverse effect associated with antiplatelet therapy after MI?

• A. Increased risk of bleeding
• B. Weight gain
• C. Hair loss
• D. Hypoglycemia

Answer: (A)

Antiplatelet therapy after a myocardial infarction works by blocking platelet function to prevent new clots. Because platelets are less able to form clots, there’s a higher risk of bleeding. This can range from minor issues like easy bruising or nosebleeds to more serious bleeds such as gastrointestinal or intracranial hemorrhage. The other options aren’t typical adverse effects of these drugs—weight gain, hair loss, and hypoglycemia aren’t commonly linked to antiplatelet therapy. So the common adverse effect to watch for is increased bleeding risk.

Antiplatelet therapy after a myocardial infarction works by blocking platelet function to prevent new clots. Because platelets are less able to form clots, there’s a higher risk of bleeding. This can range from minor issues like easy bruising or nosebleeds to more serious bleeds such as gastrointestinal or intracranial hemorrhage. The other options aren’t typical adverse effects of these drugs—weight gain, hair loss, and hypoglycemia aren’t commonly linked to antiplatelet therapy. So the common adverse effect to watch for is increased bleeding risk.